Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

[1]  Gerard J Fitzsimmons,et al.  From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.

[2]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.

[3]  F. Carrat,et al.  Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[4]  F. Carrat,et al.  Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased , 2012, The American Journal of Gastroenterology.

[5]  W. Sandborn,et al.  Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry , 2012, The American Journal of Gastroenterology.

[6]  Christopher F. Martin,et al.  Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. , 2012, Gastroenterology.

[7]  M. Durlik,et al.  Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study , 2012, Virology Journal.

[8]  D. Hunter,et al.  Use of tanning beds and incidence of skin cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Harminder Singh,et al.  Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. , 2011, Gastroenterology.

[10]  J. Hugot,et al.  Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. , 2011, Gastroenterology.

[11]  Paul Emery,et al.  Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis , 2011, Annals of the rheumatic diseases.

[12]  Harminder Singh,et al.  Screening for cervical and breast cancer among women with inflammatory bowel disease: A population‐based study , 2011, Inflammatory bowel diseases.

[13]  M. Candiani,et al.  Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  Yongqiang Deng,et al.  In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  Tao Zhang,et al.  Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia. , 2011, Rheumatology.

[16]  E. Klumb,et al.  Are women with lupus at higher risk of HPV infection? , 2010, Lupus.

[17]  C. Porter,et al.  Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  N. Segnan,et al.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J. Lear,et al.  Non-melanoma skin cancer , 2010, The Lancet.

[20]  U. Mercado.  [Abnormal cervicovaginal cytology in women with rheumatoid arthritis]. , 2010, Ginecología y Obstetricia de México.

[21]  C. Lees,et al.  Lack of association between cervical dysplasia and IBD: A large case–control study , 2009, Inflammatory bowel diseases.

[22]  C. Christodoulou,et al.  Human papilloma viruses and cancer in the post-vaccine era. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  H. Sokol,et al.  Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle , 2009, Gut.

[24]  C. Porter,et al.  Suboptimal rates of cervical testing among women with inflammatory bowel disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  E. Kliewer,et al.  Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. , 2009, Gastroenterology.

[26]  S. Allinson,et al.  Cellular and sub-cellular responses to UVA in relation to carcinogenesis , 2009, International journal of radiation biology.

[27]  A. Courtney,et al.  The uptake of cervical cancer screening by renal transplant recipients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  J. Ferlay,et al.  Incidence and mortality from non‐Hodgkin lymphoma in Europe: The end of an epidemic? , 2008, International journal of cancer.

[29]  P. Karran,et al.  PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients , 2008, British Journal of Cancer.

[30]  D. Kemptner,et al.  Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis , 2008, BMC gastroenterology.

[31]  S. Hutfless,et al.  Screening differences and risk of cervical cancer in inflammatory bowel disease , 2008, Alimentary pharmacology & therapeutics.

[32]  R. Panaccione,et al.  Hepatosplenic T cell lymphoma in inflammatory bowel disease , 2008, Gut.

[33]  M. Feltkamp,et al.  Beta-papillomavirus infection and skin cancer. , 2008, The Journal of investigative dermatology.

[34]  G. Williams.  Antitumor necrosis factor-alpha therapy and potential cancer inhibition. , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[35]  S. Kane,et al.  Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.

[36]  K. Aozasa,et al.  Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein–Barr virus infection , 2008, Leukemia.

[37]  D. van Baarle,et al.  Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients , 2008, Leukemia & lymphoma.

[38]  T. M. Rünger.  How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses. , 2007, The Journal of investigative dermatology.

[39]  F. Baldanti,et al.  Preemptive Therapy of EBV‐Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  J. Dillner,et al.  Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[41]  Rachel E Neale,et al.  Basal cell carcinoma on the trunk is associated with excessive sun exposure. , 2007, Journal of the American Academy of Dermatology.

[42]  A. Halpern,et al.  Melanoma survivorship: research opportunities , 2007, Journal of cancer survivorship : research and practice.

[43]  S. Mannor,et al.  Abnormalities of uterine cervix in women with inflammatory bowel disease. , 2006, World journal of gastroenterology.

[44]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[45]  A. Iliadou,et al.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[46]  H. Comber,et al.  A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.

[47]  C. Meijer,et al.  HPV‐mediated cervical carcinogenesis: concepts and clinical implications , 2006, The Journal of pathology.

[48]  K. Ekström-Smedby,et al.  Epidemiology and etiology of non-Hodgkin lymphoma – a review , 2006, Acta oncologica.

[49]  B. Diffey,et al.  Skin cancer incidence and the ageing population , 2005, The British journal of dermatology.

[50]  C. Brensinger,et al.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.

[51]  Richard A Scolyer,et al.  Cutaneous melanoma , 2005, The Lancet.

[52]  D. Fan,et al.  Regulation of apoptosis by the papillomavirus E6 oncogene. , 2005, World journal of gastroenterology.

[53]  W. Mccune,et al.  Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. , 2004, The Journal of rheumatology.

[54]  H. Lorenz,et al.  Basal Cell and Squamous Cell Carcinomas of the Skin , 2004 .

[55]  P. Macpherson,et al.  Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. , 2004, Blood.

[56]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.

[57]  H. Anton-Culver,et al.  Etiologic Pathogenesis of Melanoma , 2004, Clinical Cancer Research.

[58]  J. Nicolas,et al.  Epstein-Barr Virus Viral Load in Crohn’s Disease: Effect of Immunosuppressive Therapy , 2004, Inflammatory bowel diseases.

[59]  Frederick C Beddingfield.  The melanoma epidemic: res ipsa loquitur. , 2003, The oncologist.

[60]  H. Bartelink,et al.  European Code Against Cancer and scientific justification: third version (2003). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  Diane Solomon,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2003, Journal of lower genital tract disease.

[62]  D. Berg,et al.  Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. , 2002, Journal of the American Academy of Dermatology.

[63]  B. Cribier,et al.  Variations of basal cell carcinomas according to gender, age, location and histopathological subtype , 2002, The British journal of dermatology.

[64]  X. Mariette,et al.  Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. , 2002, Blood.

[65]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.

[66]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[67]  R. Graham-Brown,et al.  Letter from the Editorial Team , 2002 .

[68]  C. Brensinger,et al.  Inflammatory bowel disease is not associated with an increased risk of lymphoma. , 2001, Gastroenterology.

[69]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[70]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[71]  Jaap M Middeldorp,et al.  Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. , 2001, Blood.

[72]  R. Stern,et al.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.

[73]  K. Malinovszky,et al.  Changing trends in non‐melanoma skin cancer in South Wales, 1988–98 , 2000, The British journal of dermatology.

[74]  M. Peterson,et al.  Increased cervical dysplasia in intravenous cyclophosphamidetreated patients with SLE: a preliminary study , 2000, Lupus.

[75]  R. Stern,et al.  Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.

[76]  A. Zinsmeister,et al.  Risk of lymphoma in inflammatory bowel disease. , 2000 .

[77]  J. Kaldor,et al.  Risk of cancer in people with AIDS. , 1999, AIDS.

[78]  P. Buettner,et al.  Incidence rates of skin cancer in Townsville, Australia , 1998, International journal of cancer.

[79]  L Beardsley,et al.  Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.

[80]  W. Harmsen,et al.  Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. , 1997, Archives of dermatology.

[81]  Bruce K. Armstrong,et al.  Sunlight and cancer , 1997, Cancer Causes & Control.

[82]  S. Rosso,et al.  The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. , 1996, British Journal of Cancer.

[83]  I. Penn.  Cancers in cyclosporine-treated vs azathioprine-treated patients. , 1996, Transplantation proceedings.

[84]  Pär Sparén,et al.  HPV and cervical cancer , 2018 .

[85]  P J Heenan,et al.  A dose‐response curve for sun exposure and basal cell carcinoma , 1995, International journal of cancer.

[86]  R. Westendorp,et al.  Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. , 1995, Gut.

[87]  J. Soulé,et al.  Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. , 1994, The New England journal of medicine.

[88]  M. Kamm,et al.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease , 1994, The Lancet.

[89]  H. Adami,et al.  Extracolonic malignancies in inflammatory bowel disease , 1991, Cancer.

[90]  R. Carroll,et al.  Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.

[91]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[92]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.

[93]  N. Hou,et al.  Epidemiology and etiology of non-hodgkin lymphoma. , 2015, Cancer treatment and research.

[94]  D. Porter,et al.  A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[95]  J. Stockman.  Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2011 .

[96]  H. Tilg,et al.  European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[97]  K. Hemminki,et al.  Cancer risks in Crohn disease patients. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[98]  H. zur Hausen,et al.  Papillomaviruses in the causation of human cancers - a brief historical account. , 2009, Virology.

[99]  B. Thiers.  Human Papillomavirus Infection and Incidence of Squamous Cell and Basal Cell Carcinomas of the Skin , 2007 .

[100]  B. Thiers.  The Photocarcinogenic Risk of Narrowband UVB (TL-01) Phototherapy: Early Follow-up Data , 2006 .

[101]  A. Zinsmeister,et al.  Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. , 2002, Gastroenterology.

[102]  Evan R. Myers,et al.  Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review , 2001 .

[103]  P Jensen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.

[104]  R. Warnke,et al.  Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. , 1995, Leukemia & lymphoma.

[105]  P. Morosini,et al.  Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. , 1995, European journal of gynaecological oncology.

[106]  N. Segnan,et al.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. , 1993, European journal of cancer.

[107]  N. Golden,et al.  in Women with , 1992 .

[108]  C. Boring,et al.  Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.

[109]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.